LONG-TERM EFFECTS OF NALBUPHINE ER TABLETS IN HEMODIALYSIS PATIENTS WITH UREMIC PRURITUS: A MULTICENTER OPEN-LABEL TRIAL

被引：0

作者：

Kumar, Jayant ^{[1
]}

Crawford, Paul ^{[1
]}

Mathur, Vandana ^{[1
]}

Sciascia, Thomas ^{[1
]}

机构：

[1] Renal Med Associates, Albuquerque, NM USA

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 2016年 / 67卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

184

引用

页码：A64 / A64

页数：1

共 50 条

[41] Long-Term Assessment of the Safety and Efficacy of PA21 (Sucroferric Oxyhydroxide) in Japanese Hemodialysis Patients With Hyperphosphatemia: An Open-Label, Multicenter, Phase III Study
Koiwa, Fumihiko
Yokoyama, Keitaro
Fukagawa, Masafumi
Akizawa, Tadao
JOURNAL OF RENAL NUTRITION, 2017, 27 (05) : 346 - 354
[42] A multicenter, open-label, long-term study of three-year infliximab administration in Japanese patients with ankylosing spondylitis
Kobayashi, Shigeto
Yoshinari, Toru
MODERN RHEUMATOLOGY, 2017, 27 (01) : 142 - 149
[43] An Open-Label, Long-Term Safety and Tolerability Trial of Diclofenac Sodium I% Gel in Patients with Knee Osteoarthritis
Peniston, John H.
Gold, Morris S.
Alwine, Lawrence K.
PHYSICIAN AND SPORTSMEDICINE, 2011, 39 (03): : 31 - 38
[44] Long-term treatment with lasmiditan in patients with migraine: Results from the open-label extension of the CENTURION randomized trial
Ashina, Messoud
Roos, Caroline
Li, Lily Qian
Komori, Mika
Ayer, David
Ruff, Dustin
Krege, John Henry
CEPHALALGIA, 2023, 43 (04)
[45] Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis
Dellon, Evan S.
Collins, Margaret H.
Rothenberg, Marc E.
Assouline-Dayan, Yehudith
Evans, Larry
Gupta, Sandeep
Schoepfer, Alain
Straumann, Alex
Safroneeva, Ekaterina
Rodriguez, Cristian
Minton, Neil
Hua, Steven Y.
Hirano, Ikuo
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (03) : 473 - +
[46] Hybrid minimally invasive vs. open esophagectomy for patients with esophageal cancer: Long-term outcomes of a multicenter, open-label, randomized phase III controlled trial, the MIRO trial
Mariette, C.
Markar, S.
Dabakuyo-Yonli, T. S.
Meunier, B.
Pezet, D.
Collet, D.
D'Journo, X. B.
Brigand, C.
Perniceni, T.
Carrere, N.
Bonnetain, F.
Piessen, G.
ANNALS OF ONCOLOGY, 2017, 28
[47] Effectiveness of a Nutritional Mobile Application for Management of Hyperphosphatemia in Patients on Hemodialysis: A Multicenter Open-Label Randomized Clinical Trial
Teong, Lee-Fang
Khor, Ban-Hock
Ng, Hi-Ming
Sahathevan, Sharmela
Purba, Kristo Radion
Narayanan, Sreelakshmi Sankara
Gafor, Abdul Halim Abdul
Goh, Bak-Leong
Bee, Boon-Cheak
Yahya, Rosnawati
Bavanandan, Sunita
Wahab, Zaimi
Mazlan, Sadanah Aqashiah
Chinna, Karuthan
Morad, Zaki
Daud, Zulfitri Azuan Mat
Karupaiah, Tilakavati
JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (06):
[48] Long-Term Effects of Oral Nutritional Supplements After Gastrectomy for Gastric Cancer: A Survival Analysis from a Multicenter, Open-Label, Randomized Controlled Trial
Omori, Takeshi
Yamamoto, Kazuyoshi
Kurokawa, Yukinori
Miyazaki, Yasuhiro
Fujitani, Kazumasa
Kawabata, Ryohei
Imamura, Hiroshi
Takeno, Atsushi
Yanagimoto, Yoshitomo
Takahashi, Tsuyoshi
Saito, Takuro
Eguchi, Hidetoshi
Doki, Yuichiro
ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (10) : 6909 - 6917
[49] Long-term weight loss observed with olanzapine orally disintegrating tablets in overweight patients with chronic schizophrenia. A 1 year open-label, prospective trial
Chawla, Bharat
Luxton-Andrewl, Heather
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2008, 23 (03) : 211 - 216
[50] THE GASTROINTESTINAL-TRACT IN UREMIC PATIENTS ON LONG-TERM HEMODIALYSIS
MILITO, G
TACCONEGALLUCCI, M
BRANCALEONE, C
NARDI, F
CESCA, D
BOFFO, V
CASCIANI, CU
KIDNEY INTERNATIONAL, 1985, : S157 - S160

← 1 2 3 4 5 →